- Home
- UBFO vs ENLV Comparison
UBFO vs ENLV Comparison
Compare UBFO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBFO | ENLV |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 196.2M |
| IPO Year | 2001 | 2014 |
Fundamental Metrics
Financial Performance| Metric | UBFO | ENLV |
|---|---|---|
| Price | $10.46 | $0.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 257.4K | ★ 261.6K |
| Earning Date | 04-17-2026 | 05-29-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $2,954,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.01 | ★ N/A |
| Revenue Growth | ★ 1.23 | N/A |
| 52 Week Low | $8.11 | $0.66 |
| 52 Week High | $11.52 | $2.10 |
Technical Indicators
Market Signals| Indicator | UBFO | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 31.54 |
| Support Level | $9.31 | $0.66 |
| Resistance Level | $10.53 | $1.25 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 75.00 | 6.71 |
Price Performance
Historical ComparisonAbout UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.